Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study
Conclusions
Bevacizumab acutely impairs microvascular function independent of blood pressure changes. Imaging of the retinal microcirculation seems a valuable tool for monitoring pharmacodynamic effects of bevacizumab.
Trial registration
NCT ID: NCT00740168
Source: Experimental and Translational Stroke Medicine - Category: Neurology Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Colon Cancer | Colorectal Cancer | Heart | Neurology | Nitroglycerin | Stroke | Study